Preventive Therapy In Hemophilia B using very low dose Factor IX.
Not Applicable
Completed
- Conditions
- Health Condition 1: D67- Hereditary factor IX deficiency
- Registration Number
- CTRI/2020/06/025789
- Lead Sponsor
- Maulana Azad Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
Patients with age greater than 13 years diagnosed as Severe Hemophilia B.
Exclusion Criteria
Patients with other bleeding disorders like Von Willebrands Disease
Patients with any liver disease or kidney disease
Patients on anticoagulation therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To estimate annual bleed rate in Severe Hemophilia B patientsTimepoint: Less than or equal to one year
- Secondary Outcome Measures
Name Time Method To calculate anti Hemophilic Factor usedTimepoint: Less than or equal to one year;To check compliance of patientsTimepoint: Less than or equal to one year;To check functional disability by FISH( Functional Independence Score In Hemophilia)Timepoint: Less than or equal to one year